Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Séverine, Fraboulet"'
Autor:
Pierre, Mordant, Solenn, Brosseau, Bernard, Milleron, Nicola, Santelmo, Séverine, Fraboulet-Moreau, Benjamin, Besse, Alexandra, Langlais, Dominique, Gossot, Pascal-Alexandre, Thomas, Jean-Louis, Pujol, Charles, Ricordel, Jeannick, Madelaine, Régine, Lamy, Clarisse, Audigier-Valette, Pascale, Missy, Hélène, Blons, Fabrice, Barlesi, Virginie, Westeel
Publikováno v:
Clinical Lung Cancer
Clinical Lung Cancer, 2023, 24 (1), pp.1-10. ⟨10.1016/j.cllc.2022.08.013⟩
Clinical Lung Cancer, 2023, 24 (1), pp.1-10. ⟨10.1016/j.cllc.2022.08.013⟩
International audience; INTRODUCTION: Molecular profile of resected stage I-II non-small cell lung cancer (NSCLC) would help refine prognosis and personalize induction or adjuvant strategies. We sought to report the molecular profile of resected stag
Autor:
Bruno Coudert, Bénédicte Mastroianni, P. Foucher, Séverine Fraboulet, Adrien Dixmier, Julien Mazieres, Michel Vincent, Eric Dansin, Eric Pichon, M. Locatelli-Sanchez, Jacques Cadranel, Sébastien Couraud, N. Baize, Isabelle Monnet, Franck Morin, Catherine Dubos-Arvis, P. Missy, C. Fontaine-Delaruelle, Patrick Dumont, Denis Moro-Sibilot
Publikováno v:
Respiratory Medicine and Research
Respiratory Medicine and Research, Elsevier, 2020, 77, pp.58-66. ⟨10.1016/j.resmer.2020.01.003⟩
Respiratory Medicine and Research, Elsevier, 2020, 77, pp.58-66. ⟨10.1016/j.resmer.2020.01.003⟩
Background Lung cancer in women is on the rise, with a higher proportion occurring in lifelong never-smokers. Lung cancer in never-smokers (LCINS) exhibits a high frequency of driver oncogene alterations. In this study, we aimed to investigate whethe
Autor:
Séverine Fraboulet, Alexandre Chabrol, Hélène Salvator, Louis-Jean Couderc, Aurélie Le Gal, Anne-Laure Brun
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 204:e134-e135
Autor:
Audrey Lupo, Ségolène Hescot, Matthieu Glorion, Hélène Doubre, Louis-Jean Couderc, Diane Damotte, Elisabeth Longchampt, Séverine Fraboulet
Publikováno v:
Clinical lung cancer. 22(5)
Autor:
Sylvie Friard, Marie-Ange Massiani, Christos Chouaid, Hélène Doubre, Anne-cecile Metivier, Leila Zemoura, Laure Tabèze, Marie Mayenga, Céline Callens, Elisabeth Longchampt, Jean-Baptiste Assié, Samia Melaabi, Isabelle Monnet, Séverine Fraboulet, Louis-Jean Couderc
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 150
About 2-3% of non-small-cell lung cancers (NSCLCs) harbor MET exon-14-skipping (METex14) mutations. Efficacy of the MET-inhibitor crizotinib has been reported, but progression-free survival (PFS) was very short. Immune-checkpoint inhibitors (ICIs) ha
Autor:
Philippe Masson, Denis Moro-Sibilot, Isabelle Monnet, Anne-Claire Toffart, Bertrand Mennecier, Didier Debieuvre, E. Amour, Eric Pichon, Fabrice Barlesi, Olivier Molinier, Franck Morin, Patrick Aldo Renault, Anne Madroszyk-Flandin, Séverine Fraboulet, Isabelle Rouquette, Alexis B. Cortot, Pierre Jean Souquet, Virginie Westeel, Sandrine Hiret, Clarisse Audigier-Valette, Julien Mazieres, Benjamin Besse, Gérard Zalcman
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(13)
Purpose: The incidence of lung cancer has dramatically increased in women. Preclinical data have suggested that combining EGFR–tyrosine kinase inhibitor (TKI) with an antiestrogen may overcome resistance to EGFR-TKI. Patients and Methods: The IFCT-
Autor:
Julien Mazieres, Pascal Do, Gérard Zalcman, O. Bylicki, Jacques Cadranel, Sylvie Lantuejoul, Franck Morin, Florian Guisier, Laurent Greillier, David Planchard, Olivier Molinier, Clarisse Audigier-Valette, Didier Debieuvre, Catherine Ligeza-poisson, M. Locatelli-Sanchez, Romain Corre, Delphine Carmier, Thierry Urban, Isabelle Monnet, Denis Moro-Sibilot, E. Amour, Arnaud Scherpereel, Sandrine Hiret, Séverine Fraboulet-Moreau
Publikováno v:
The Lancet Oncology
The Lancet Oncology, 2019, 20 (2), pp.239-253. ⟨10.1016/S1470-2045(18)30765-4⟩
The Lancet Oncology, 2019, 20 (2), pp.239-253. ⟨10.1016/S1470-2045(18)30765-4⟩
There is no recommended therapy for malignant pleural mesothelioma that has progressed after first-line pemetrexed and platinum-based chemotherapy. Disease control has been less than 30% in all previous studies of second-line drugs. Preliminary resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae99b54465162f6dcacf656787abcc08
https://hal.archives-ouvertes.fr/hal-02570690
https://hal.archives-ouvertes.fr/hal-02570690
Autor:
Hélène Salvator, Emilie Catherinot, Alexandre Chabrol, Hélèe Doubre, Elisabeth Rivaud, Louis Jean Couderc, Sylvie Friard, Abdul Momen Hamid, Marie-Camille Chaumais, David Montani, Séverine Fraboulet, Colas Tcherakian, Marie Mayenga, Anne-cecile Metivier
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 120
We report here the first cases, to our knowledge, of pulmonary arterial hypertension induced by lorlatinib. It s the first time that a tyrosine kinase inhibitor for lung cancer is associated with pulmonary arteriel hypertension.
Autor:
Christophe Legendre, Elisabeth Longchampt, Claire Rousseau-Gazaniol, Leila Tricot, Gaëlle Pellé, Frank Martinez, Michel Delahousse, Henri Kreis, Dany Anglicheau, Pierre Bonnette, Philippe Puyo, Patricia Moisson, François Mellot, Séverine Fraboulet, Louis-Jean Couderc, Sylvie Friard, Alain Chapelier, Emilie Catherinot, Raphael Borie, Abdul Monem Hamid, Marie-Ange Massiani, Leila Zemoura, Edouard Sage, Hélène Doubre
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 111
Introduction Solid organ transplant patients are at heightened risk of several cancers compared to the general population. Secondary to a higher number of procedures and better survival after transplantation, cancer is a rising health concern in this
Autor:
Christophe, Paris, Pascal, Do, Bénédicte, Mastroianni, Adrien, Dixmier, Patrick, Dumont, Eric, Pichon, Christos, Chouaid, Bruno, Coudert, Pascal, Foucher, Séverine, Fraboulet, Myriam, Locatelli-Sanchez, Nathalie, Baize, Eric, Dansin, Lionel, Moreau, Michel, Vincent, Pascale, Missy, Franck, Morin, Denis, Moro-Sibilot, Sébastien, Couraud, Etienne, Suc
Publikováno v:
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2017, 50 (4), pp.1700716. ⟨10.1183/13993003.00716-2017⟩
European Respiratory Journal, 2017, 50 (4), pp.1700716. ⟨10.1183/13993003.00716-2017⟩
European Respiratory Journal, European Respiratory Society, 2017, 50 (4), pp.1700716. ⟨10.1183/13993003.00716-2017⟩
European Respiratory Journal, 2017, 50 (4), pp.1700716. ⟨10.1183/13993003.00716-2017⟩
Occupational exposure constitutes a common risk factor for lung cancer. We observed molecular alterations in 73% of never-smokers, 35% of men and 8% of women were exposed to at least one occupational carcinogen. We report herein associations between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f5b039579ea58028a02427ac9cb998
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01647080
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01647080